Form 4 Tracker
Michael J Berendt

Director · 2 filings · Latest: Oct 13, 2026

Retension Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing